| Patent | Date |
|---|
Compounds and methods for treating oxalate-related diseases
Grant 11,389,456 - Keller , et al. July 19, 2 | 2022-07-19 |
Compounds And Methods For Treating Oxalate-related Diseases
App 20200390778 - KELLER; Bradley T. ; et al. | 2020-12-17 |
Nucleic acids encoding antibodies to CCR2
Grant 9,238,691 - Gladue , et al. January 19, 2 | 2016-01-19 |
Antibodies To Ccr2
App 20140342450 - Gladue; Ronald P. ; et al. | 2014-11-20 |
Bile Acid Recycling Inhibitors For Treatment Of Barrett's Esophagus And Gastroesophageal Reflux Disease
App 20140271734 - GEDULIN; Bronislava ; et al. | 2014-09-18 |
Bile Acid Recycling Inhibitors For Treatment Of Primary Sclerosing Cholangitis And Inflammatory Bowel Disease
App 20140275090 - GEDULIN; Bronislava ; et al. | 2014-09-18 |
Antibodies to CCR2
Grant 8,710,191 - Gladue , et al. April 29, 2 | 2014-04-29 |
Antibodies To Ccr2
App 20110274696 - Gladue; Ronald P. ; et al. | 2011-11-10 |
Combinations of Cholesterol Ester Transfer Protein Inhibitors and HMG COA Reductase Inhibitors for Cardiovascular Indications
App 20070203246 - Keller; Bradley T. ; et al. | 2007-08-30 |
Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
App 20060003975 - Keller; Bradley T. ; et al. | 2006-01-05 |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors
Grant 6,943,189 - Keller , et al. September 13, 2 | 2005-09-13 |
Therapeutic combinations for cardiovascular and inflammatory indications
App 20040186154 - Seibert, Karen ; et al. | 2004-09-23 |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
App 20040157915 - Keller, Bradley T. ; et al. | 2004-08-12 |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
App 20040110761 - Keller, Bradley T. ; et al. | 2004-06-10 |
Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
App 20040067918 - Keller, Bradley T. ; et al. | 2004-04-08 |
Combinations for cardiovascular indications
App 20040058908 - Keller, Bradley T. ; et al. | 2004-03-25 |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
App 20040048846 - Keller, Bradley T. ; et al. | 2004-03-11 |
Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
App 20040029845 - Keller, Bradley T. ; et al. | 2004-02-12 |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
App 20030232834 - Keller, Bradley T ; et al. | 2003-12-18 |
Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
App 20030219401 - Keller, Bradley T. ; et al. | 2003-11-27 |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
Grant 6,642,268 - Keller , et al. November 4, 2 | 2003-11-04 |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
App 20030203892 - Keller, Bradley T. ; et al. | 2003-10-30 |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
Grant 6,638,969 - Keller , et al. October 28, 2 | 2003-10-28 |
Therapeutic combinations for cardiovascular and inflammatory indications
App 20030199482 - Seibert, Karen ; et al. | 2003-10-23 |
Combination therapy employing ileal bile acid transport inhibiting benzothiepiens and HMG Co-A reductase inhibitors
App 20030171426 - Keller, Bradley T. ; et al. | 2003-09-11 |
Combinations of cholesteryl ester transfer protein inhibitors and HMG CoA reductase inhibitors for cardiovascular indications
App 20030166712 - Keller, Bradley T. ; et al. | 2003-09-04 |
Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor
App 20030149010 - Keller, Bradley T. ; et al. | 2003-08-07 |
Combinations of lleal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
App 20030125316 - Keller, Bradley T. ; et al. | 2003-07-03 |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
Grant 6,458,851 - Keller , et al. October 1, 2 | 2002-10-01 |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
Grant 6,420,417 - Keller , et al. July 16, 2 | 2002-07-16 |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
App 20020061888 - Keller, Bradley T. ; et al. | 2002-05-23 |
| 